secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2025-03-14T23:59:59+00:00
Accession:  0001178913-25-000836
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silexion retires $880K convertible note with $400K cash and 277,777 shares
--------------------------------------------------------------------------

- Agreed to retire $880,202.20 outstanding convertible note issued to EarlyBirdCapital; pays $400K cash plus $15K legal fees.
- Issues 277,777 ordinary shares to EBC as part of conversion; shares registered under Form S-1.
- Any remaining balance after cash and net proceeds from share sales to be settled in further cash payment.
- Note originally dated Aug 15, 2024 for $1.25M, due Dec 31, 2025; now fully retired after this agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325000836/0001178913-25-000836-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325000836/zk2532868.htm
  HTML page:      https://secwatch.observer/filing/0001178913-25-000836

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer